日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Real-world management practices and characteristics of patients with advanced melanoma initiated on immuno-oncology or targeted therapy in the first-line setting during the period 2015-2018 in Greece. The 'SUMMER' study: a retrospective multicenter chart review project

2015-2018年希腊晚期黑色素瘤患者一线接受免疫肿瘤学或靶向治疗的真实世界管理实践和特征。“SUMMER”研究：一项回顾性多中心病历审查项目

期刊:Melanoma Research
影响因子:1.9
doi:10.1097/CMR.0000000000000949
Bafaloukos, Dimitrios; Kouzis, Panagiotis; Gouveris, Panagiotis; Boukovinas, Ioannis; Kalbakis, Konstantinos; Baka, Sofia; Kyriakakis, Georgios; Moschou, Despoina; Molfeta, Aristea; Demiri, Stamatia; Mavroudis, Dimitrios; Spanoudi, Filio; Dimitriadis, Ioannis; Gogas, Helen
黑色素瘤
肿瘤
肿瘤免疫
多发性骨髓瘤
MME
免疫/内分泌
发表日期：2024
文献求助 收藏

Front-Line Bevacizumab plus Chemotherapy with or without Maintenance Therapy for Metastatic Breast Cancer: An Observational Study by the Hellenic Oncology Research Group

一线贝伐珠单抗联合化疗（伴或不伴维持治疗）治疗转移性乳腺癌：希腊肿瘤研究组的一项观察性研究

期刊:Current Oncology
影响因子:3.4
doi:10.3390/curroncol29020105
Kokkali, Stefania; Saloustros, Emmanouil; Stefanou, Dimitra; Makrantonakis, Paris; Kentepozidis, Nikolaos; Boukovinas, Ioannis; Xenidis, Nikolaos; Katsaounis, Panagiotis; Ardavanis, Alexandros; Ziras, Nikolaos; Christopoulou, Athina; Rigas, George; Kalbakis, Kostas; Vardakis, Nikolaos; Emmanouilides, Christos; Athanasiadis, Ilias; Anagnostopoulos, Athanassios; Hatzidaki, Dora; Prinarakis, Efthimios; Simopoulou, Foteini; Kotsakis, Athanasios; Georgoulias, Vassilis
肿瘤
肿瘤免疫
乳腺癌
发表日期：2022
文献求助 收藏

Objective Response to First-Line Treatment as a Predictor of Overall Survival in Metastatic Breast Cancer: A Retrospective Analysis from Two Centers over a 25-Year Period

一线治疗客观缓解率作为转移性乳腺癌患者总生存期的预测指标：一项来自两个中心25年回顾性分析

期刊:Breast Care
影响因子:2.1
doi:10.1159/000519729
Matikas, Alexios; Kotsakis, Athanasios; Perraki, Maria; Hatzidaki, Dora; Kalbakis, Konstantinos; Kontopodis, Emmanouil; Nikolaou, Michail; Georgoulias, Vasilios
肿瘤
肿瘤免疫
乳腺癌
发表日期：2022
文献求助 收藏

Cancer cachexia syndrome and clinical outcome in patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors: results from a prospective, observational study

癌症恶病质综合征与接受PD-1/PD-L1抑制剂治疗的转移性非小细胞肺癌患者的临床结局：一项前瞻性观察研究的结果

期刊:Translational Lung Cancer Research
影响因子:3.5
doi:10.21037/tlcr-21-460
Rounis, Konstantinos; Makrakis, Dimitrios; Tsigkas, Alexandros-Pantelis; Georgiou, Alexandra; Galanakis, Nikolaos; Papadaki, Chara; Monastirioti, Alexia; Vamvakas, Lambros; Kalbakis, Konstantinos; Vardakis, Nikolaos; Kontogianni, Meropi; Gioulbasanis, Ioannis; Mavroudis, Dimitrios; Agelaki, Sofia
肺癌
肿瘤
肿瘤免疫
PD-L1
细胞生物学
PD-1
发表日期：2021
文献求助 收藏

Prediction of outcome in patients with non-small cell lung cancer treated with second line PD-1/PDL-1 inhibitors based on clinical parameters: Results from a prospective, single institution study

基于临床参数预测接受二线PD-1/PDL-1抑制剂治疗的非小细胞肺癌患者的预后：一项前瞻性单中心研究的结果

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0252537
Rounis, Konstantinos; Makrakis, Dimitrios; Papadaki, Chara; Monastirioti, Alexia; Vamvakas, Lambros; Kalbakis, Konstantinos; Gourlia, Krystallia; Xanthopoulos, Iordanis; Tsamardinos, Ioannis; Mavroudis, Dimitrios; Agelaki, Sofia
肺癌
肿瘤
肿瘤免疫
细胞生物学
PD-1
发表日期：2021
文献求助 收藏

Circulating MicroRNAs Regulating DNA Damage Response and Responsiveness to Cisplatin in the Prognosis of Patients with Non-Small Cell Lung Cancer Treated with First-Line Platinum Chemotherapy

循环microRNA调控DNA损伤反应和对顺铂的反应性在接受一线铂类化疗的非小细胞肺癌患者预后中的作用

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers12051282
Papadaki, Chara; Monastirioti, Alexia; Rounis, Konstantinos; Makrakis, Dimitrios; Kalbakis, Konstantinos; Nikolaou, Christoforos; Mavroudis, Dimitrios; Agelaki, Sofia
肺癌
肿瘤
肿瘤免疫
信号转导
细胞生物学
毒理研究
发表日期：2020
文献求助 收藏

Brain and bone marrow metastases from rectal cancer

直肠癌脑转移和骨髓转移

期刊:Annals of Gastroenterology
影响因子:2.2
doi:10.20524/aog.2019.0423
Thomopoulou, Konstantina; Manolakou, Stavroula; Messaritakis, Ippokratis; Tzardi, Maria; Lagoudaki, Eleni; Koutsopoulos, Anastasios; Koulouris, Andreas; Kanellis, George; Kalbakis, Konstantinos; Mavroudis, Dimitris; Souglakos, Ioannis
肿瘤
肠癌
肿瘤免疫
神经科学
发表日期：2020
文献求助 收藏

Nab-paclitaxel as second-line treatment in advanced gastric cancer: a multicenter phase II study of the Hellenic Oncology Research Group

纳米白蛋白紫杉醇作为晚期胃癌二线治疗：希腊肿瘤研究组的一项多中心II期研究

期刊:Annals of Gastroenterology
影响因子:2.2
doi:10.20524/aog.2017.0215
Katsaounis, Panagiotis; Kotsakis, Athanasios; Kentepozidis, Nikolaos; Polyzos, Aris; Bakogeorgos, Marios; Koinis, Filippos; Vamvakas, Lambros; Vardakis, Nikolaos; Kalbakis, Kostas; Boukovinas, Ioannis; Varthalitis, Ioannis I; Prinarakis, Efthimios; Georgoulias, Vassilis; Souglakos, John
胃癌
肿瘤
肿瘤免疫
发表日期：2018
文献求助 收藏

Differential effect of adjuvant taxane-based and taxane-free chemotherapy regimens on the CK-19 mRNA-positive circulating tumour cells in patients with early breast cancer

辅助性紫杉烷类化疗方案与不含紫杉烷类化疗方案对早期乳腺癌患者循环肿瘤细胞中CK-19 mRNA阳性细胞的不同影响

期刊:British Journal of Cancer
影响因子:6.8
doi:10.1038/bjc.2012.597
Xenidis, N; Perraki, M; Apostolaki, S; Agelaki, S; Kalbakis, K; Vardakis, N; Kalykaki, A; Xyrafas, A; Kakolyris, S; Mavroudis, D; Georgoulias, V
肿瘤
肿瘤免疫
乳腺癌
细胞生物学
肿瘤细胞
发表日期：2013
文献求助 收藏

A triplet combination with irinotecan (CPT-11), oxaliplatin (LOHP), continuous infusion 5-fluorouracil and leucovorin (FOLFOXIRI) plus cetuximab as first-line treatment in KRAS wt, metastatic colorectal cancer: a pilot phase II trial

伊立替康（CPT-11）、奥沙利铂（LOHP）、持续输注5-氟尿嘧啶和亚叶酸钙（FOLFOXIRI）联合西妥昔单抗三联疗法作为KRAS野生型转移性结直肠癌一线治疗：一项II期试点试验

期刊:British Journal of Cancer
影响因子:6.8
doi:10.1038/bjc.2012.509
Saridaki, Z; Androulakis, N; Vardakis, N; Vamvakas, L; Kabouraki, E; Kalbakis, K; Hatzidaki, D; Voutsina, A; Mavroudis, D; Georgoulias, V; Souglakos, J
RAS
肿瘤
肠癌
肿瘤免疫
发表日期：2012
文献求助 收藏